Ayuko Taniguchi Selected Research

Acute Eosinophilic Leukemia

9/2007

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayuko Taniguchi Research Topics

Disease

6	Neoplasms (Cancer) 09/2018 - 06/2007
5	Leukemia 06/2012 - 06/2007
4	Lymphoma (Lymphomas) 01/2019 - 10/2008
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2012 - 06/2007
2	Pleural Empyema (Pyothorax) 01/2019 - 01/2015
2	Disseminated Intravascular Coagulation 11/2013 - 11/2012
2	Acute Promyelocytic Leukemia 11/2012 - 06/2012
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2008 - 02/2008
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2008 - 09/2007
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2018
1	Pulmonary Tuberculosis 01/2015
1	Pleurisy (Pleuritis) 01/2015
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 08/2014
1	Coronary Thrombosis 08/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2014
1	Thrombosis (Thrombus) 08/2014
1	Multiple Myeloma 03/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2010
1	Low Back Pain (Lumbago) 09/2010
1	Fever (Fevers) 09/2010
1	Subcutaneous panniculitis-like T-cell lymphoma 09/2010
1	Lymphadenopathy 10/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2008
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 06/2008
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 06/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2007
1	Acute Eosinophilic Leukemia 09/2007
1	Blast Crisis (Blast Phase) 09/2007
1	Carcinogenesis 06/2007
1	Aneuploidy (Aneuploid) 06/2007

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 06/2008 - 06/2007
2	Dacarbazine (DIC)FDA LinkGeneric 11/2013 - 11/2012
2	ThrombomodulinIBA 11/2012 - 06/2012
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2012 - 06/2012
2	Bone Morphogenetic Protein 6IBA 03/2012 - 10/2008
2	Aurora KinasesIBA 09/2007 - 06/2007
2	ThymidineIBA 09/2007 - 06/2007
1	ChemokinesIBA 01/2019
1	Capsid Proteins (Capsid Protein)IBA 01/2015
1	eculizumab FDA Link 08/2014
1	AnticoagulantsIBA 08/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2014
1	Heparin (Liquaemin)FDA LinkGeneric 08/2014
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2014
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2014
1	Viral ProteinsIBA 01/2014
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 06/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 03/2012
1	RNA (Ribonucleic Acid)IBA 09/2010
1	Methotrexate (Mexate)FDA LinkGeneric 09/2010
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2008
1	AZD 6244IBA 06/2008
1	Sunitinib (Sutent)FDA Link 06/2008
1	NF-kappa B (NF-kB)IBA 02/2008
1	Aurora Kinase BIBA 09/2007
1	4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA 09/2007
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 09/2007
1	Topoisomerase II InhibitorsIBA 09/2007
1	TubulinIBA 09/2007
1	Annexin A5IBA 06/2007
1	DNA (Deoxyribonucleic Acid)IBA 06/2007
1	Aurora Kinase AIBA 06/2007

Therapy/Procedure

3	Therapeutics 09/2018 - 09/2010
1	Molecular Targeted Therapy 09/2018
1	Artificial Pneumothorax 01/2015
1	Drug-Eluting Stents 08/2014
1	Drug Therapy (Chemotherapy) 11/2012